HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Yogo Selected Research

mitemcinal

9/2008Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
7/2008Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
4/2008Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys.
1/2008Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
1/2007Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Yogo Research Topics

Disease

5Gastroparesis
09/2008 - 01/2007
3Osteoporosis
01/2019 - 12/2015
2Pain (Aches)
11/2021 - 01/2018
2Glomerulonephritis
01/2021 - 09/2009
2Anemia
04/2017 - 11/2015
2Body Weight (Weight, Body)
11/2015 - 09/2008
2Chronic Renal Insufficiency
11/2015 - 09/2009
2Proteinuria
01/2013 - 09/2009
2Inflammation (Inflammations)
04/2011 - 05/2004
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
08/2009 - 01/2007
2Dyspepsia (Indigestion)
04/2008 - 01/2007
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2021
1Hyperalgesia
11/2021
1Neuralgia (Stump Neuralgia)
11/2021
1Disease Progression
01/2021
1Immune System Diseases (Immune Disorders)
01/2018
1Experimental Arthritis
11/2017
1Arthritis (Polyarthritis)
11/2017
1Obesity
11/2017
1Postmenopausal Osteoporosis
02/2016
1Bone Fractures (Bone Fracture)
12/2015
1Bone Resorption
12/2015
1Thrombosis (Thrombus)
03/2015
1Hyperphosphatemia
05/2013
1Vitamin D Deficiency
05/2013
1Hypercalcemia (Milk Alkali Syndrome)
05/2013
1Type 2 Diabetes Mellitus (MODY)
05/2013
1Fibrosis (Cirrhosis)
01/2013
1Cardiovascular Diseases (Cardiovascular Disease)
11/2011
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
04/2011
1Hypertension (High Blood Pressure)
04/2011
1Hypertrophy
09/2009
1Nephritis
09/2009
1Heart Failure
09/2009
1Diarrhea
08/2009
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
11/2008
1Liver Failure
09/2008
1Hyperglycemia
09/2008
1Renal Insufficiency (Renal Failure)
09/2008
1Visceral Pain
03/2008
1Myocardial Infarction
05/2004
1Coronary Occlusion
05/2004

Drug/Important Bio-Agent (IBA)

5Nicorandil (SG 75)IBA
03/2015 - 11/2008
5mitemcinalIBA
09/2008 - 01/2007
4Interleukin-6 (Interleukin 6)IBA
11/2021 - 04/2011
3continuous erythropoietin receptor activatorFDA Link
01/2021 - 11/2015
3Vitamin DFDA LinkGeneric
02/2016 - 05/2013
3motilin receptorIBA
08/2009 - 03/2008
3MotilinIBA
08/2009 - 03/2008
2HematinicsIBA
01/2021 - 11/2015
2Parathyroid Hormone (Parathormone)IBA
01/2019 - 04/2011
2Pharmaceutical PreparationsIBA
04/2017 - 09/2009
2eldecalcitol (ED 71)IBA
02/2016 - 12/2015
2Proteins (Proteins, Gene)FDA Link
11/2015 - 01/2013
2CreatinineIBA
11/2015 - 04/2011
2MA-2029IBA
08/2009 - 03/2008
2Cisapride (Propulsid)FDA Link
07/2008 - 01/2008
1epoetin betaIBA
01/2021
1Anabolic AgentsIBA
01/2019
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2017
1Collagen Type II (Type II Collagen)IBA
11/2017
1Ibandronic Acid (Boniva)FDA Link
12/2015
1salicylhydroxamic acid (SHAM)IBA
12/2015
1Cholecalciferol (Vitamin D3)FDA Link
12/2015
1Diphosphonates (Bisphosphonates)IBA
12/2015
1Hemoglobins (Hemoglobin)IBA
11/2015
1Sirolimus (Rapamycin)FDA Link
03/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2015
1Blood Glucose (Blood Sugar)IBA
05/2013
1maxacalcitolIBA
05/2013
1Endothelins (Endothelin)IBA
01/2013
1Messenger RNA (mRNA)IBA
01/2013
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2013
1Phosphorus (Red Phosphorus)IBA
04/2011
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
04/2011
1SodiumIBA
04/2011
1Phosphates (Orthophosphate)IBA
04/2011
1Cardiotonic Agents (Cardiac Stimulants)IBA
09/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2009
1Potassium Channels (Potassium Channel)IBA
11/2008
1Nitric Oxide DonorsIBA
11/2008
1Glucose (Dextrose)FDA LinkGeneric
09/2008
1Streptozocin (Streptozotocin)FDA Link
09/2008
1Insulin (Novolin)FDA Link
09/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2004
1Collagenases (Collagenase)FDA Link
05/2004

Therapy/Procedure

1Therapeutics
11/2021
1Intraperitoneal Injections
11/2021
1Intravenous Injections
09/2008
1Intravenous Infusions
03/2008
1Oral Administration
03/2008